Yestar Healthcare Holdings Company Limited provided consolidated earnings guidance for the six months ended 30 June 2022. The company is expected to record an unaudited consolidated net loss of the Group of approximately RMB 180.2 million and an unaudited consolidated net loss attributable to the owners of the parent of approximately RMB 161.5 million for the six months ended 30 June 2022 as compared to an unaudited consolidated net profit of the Group of approximately RMB 120.9 million and an unaudited consolidated net profit attributable to the owners of the parent of approximately RMB 111.9 million for the six months ended 30 June 2021.